Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW) (STANDLOW)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03689114
Recruitment Status : Not yet recruiting
First Posted : September 28, 2018
Last Update Posted : September 27, 2019
Sponsor:
Collaborators:
Azienda Ospedaliera San Gerardo di Monza
Ministry of Health, Italy
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : December 2021
Publications: